AstraZeneca Vaccine Unlikely to Get EU Approval in January -Het Nieuwsblad
December 29 2020 - 9:34AM
Dow Jones News
--The European Medicines Agency probably won't be able to
approve AstraZeneca PLC and the University of Oxford's Covid-19
vaccine in January, says Noel Wathion, the watchdog's deputy
executive director, in an interview with Belgian newspaper Het
Nieuwsblad.
--The data submitted to the EMA by the vaccine's developers
isn't even enough to grant it a conditional marketing license,
Wathion tells Het Nieuwsblad.
Full story (in Dutch): https://bit.ly/34QhY06
Write to Barcelona editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
December 29, 2020 09:19 ET (14:19 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024
